# ADIA (Adia Med, Inc.) - SEC EDGAR Financial Statements

> Adia Med, Inc. reported $1.20M in revenue and a net loss of $498K for the trailing twelve months ended September 30, 2026 (up 36.8% year over year), with a 35.3% gross margin and a -38.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/ADIA
- Markdown: https://convexityos.com/fundamentals/ADIA.md
- SEC CIK: 0001160420
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001160420&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.20M | +36.8% YoY |
| Operating Income | TTM | -$455K | -38.0% margin |
| Net Income | TTM | -$498K | -41.5% net margin |
| Diluted EPS | TTM | -$0.01 | Split-adjusted |
| Free Cash Flow | TTM | -$326K | -27.2% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $1.14M | Total debt: $139K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Revenue** | $701K | $6.4K |
| Cost of Revenue | $509K | $4.2K |
| **Gross Profit** | $192K | $2.2K |
| Research & Development | $29K | $0 |
| Total Operating Expenses | $558K | $177K |
| **Operating Income** | -$366K | -$175K |
| **EBITDA** | -$362K | -$174K |
| Interest Income | $625 | $0 |
| Interest Expense | $32K | $6.3K |
| Income Before Tax | -$395K | -$181K |
| Income Tax Expense | $0 | $0 |
| **Net Income** | -$395K | -$181K |
| Basic EPS | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 |
| Basic Shares Outstanding | 93.6M | 91.7M |
| Diluted Shares Outstanding | 93.6M | 91.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $454K | $389K | $176K | $179K | $332K | $118K | $72K |
| Cost of Revenue | $233K | $203K | $109K | $230K | $129K | $92K | $58K |
| **Gross Profit** | $221K | $186K | $68K | -$52K | $203K | $26K | $14K |
| Research & Development | $4.4K | $0 | -- | -- | $6.2K | $25K | -- |
| Total Operating Expenses | $260K | $231K | $219K | $167K | $124K | $143K | $125K |
| **Operating Income** | -$39K | -$45K | -$152K | -$219K | $79K | -$117K | -$111K |
| **EBITDA** | -$38K | -$44K | -$151K | -$218K | $80K | -$115K | -$110K |
| Interest Income | -- | $375 | $375 | -- | -- | $0 | $0 |
| Interest Expense | $14K | -$12K | $11K | $9.4K | $9.1K | $7.4K | $5.7K |
| Income Before Tax | -$53K | -$56K | -$163K | -$226K | $70K | -$124K | -$116K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$53K | -$56K | -$163K | -$226K | $70K | -$124K | -$116K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 94.4M | 94.4M | 94.4M | -- | 91.2M | 89.6M | 95.9M |
| Diluted Shares Outstanding | 94.4M | 161.4M | 94.4M | -- | 158.2M | 89.6M | 95.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $79K | $6.3K |
| **Cash & Short-Term Investments** | $79K | $6.3K |
| Accounts Receivable, Net | $33K | $0 |
| Inventory | $25K | $207K |
| **Total Current Assets** | $162K | $258K |
| Property, Plant & Equipment, Net | $31K | $22K |
| Intangible Assets | $0 | $5.9K |
| Other Non-Current Assets | $25K | -- |
| **Total Non-Current Assets** | $433K | $408K |
| **Total Assets** | $595K | $666K |
| Accounts Payable | $2.4K | $4.9K |
| Deferred Revenue (Current) | $14K | $0 |
| **Total Current Liabilities** | $745K | $80K |
| **Total Non-Current Liabilities** | $107K | $561K |
| **Total Liabilities** | $852K | $641K |
| **Total Debt (incl. Leases)** | $198K | $261K |
| Retained Earnings | -$15.97M | -$15.58M |
| **Total Stockholders' Equity** | -$258K | $26K |
| Total Equity | -$258K | $26K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.14M | $128K | $137K | $79K | $6.3K |
| **Cash & Short-Term Investments** | $1.14M | $128K | $137K | $79K | $6.3K |
| Accounts Receivable, Net | $53K | $44K | $79K | $33K | $0 |
| Inventory | $348K | -- | -- | $25K | $207K |
| **Total Current Assets** | $1.56M | $343K | $359K | $162K | $258K |
| Property, Plant & Equipment, Net | $42K | $33K | $35K | $31K | $22K |
| Intangible Assets | -- | -- | -- | $0 | $5.9K |
| Other Non-Current Assets | $30K | -- | -- | $25K | -- |
| **Total Non-Current Assets** | $889K | $401K | $418K | $433K | $408K |
| **Total Assets** | $2.45M | $744K | $777K | $595K | $666K |
| Accounts Payable | $23K | $5.2K | $28K | $2.4K | $4.9K |
| Deferred Revenue (Current) | $140K | $64K | $218K | $14K | $0 |
| **Total Current Liabilities** | $1.44M | $1.06M | $1.11M | $745K | $80K |
| **Total Non-Current Liabilities** | $47K | $67K | $87K | $107K | $561K |
| **Total Liabilities** | $1.48M | $1.12M | $1.20M | $852K | $641K |
| **Total Debt (incl. Leases)** | $139K | $158K | $178K | $198K | $261K |
| Retained Earnings | -$16.25M | -$16.10M | -$16.14M | -$15.97M | -$15.58M |
| **Total Stockholders' Equity** | $970K | -$477K | -$420K | -$258K | $26K |
| Total Equity | $970K | -$477K | -$420K | -$258K | $26K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$395K | -$181K |
| Depreciation & Amortization | $4.1K | $433 |
| Stock-Based Compensation | $42K | $31K |
| Change in Receivables | -$33K | $0 |
| Change in Payables | -$2.5K | $4.9K |
| **Operating Cash Flow** | -$179K | -$335K |
| Capital Expenditure | -$13K | -$22K |
| **Free Cash Flow** | -$192K | -$357K |
| **Investing Cash Flow** | -$32K | -$26K |
| Common Stock Issued | $70K | $25K |
| **Financing Cash Flow** | $284K | $367K |
| **Net Change in Cash** | $73K | $5.8K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$53K | -$56K | -$163K | -$226K | $70K | -$124K | -$116K |
| Depreciation & Amortization | $1.6K | $1.4K | $1.3K | $964 | $1.3K | $1.1K | $774 |
| Stock-Based Compensation | $0 | $0 | $0 | -- | $0 | $0 | $0 |
| Change in Receivables | -$9.5K | $35K | -$46K | $72K | -$103K | -$2.3K | $0 |
| Change in Payables | $188K | -$23K | $26K | -$132 | -$471 | $533 | -$2.4K |
| **Operating Cash Flow** | -$76K | -$109K | -$55K | -$71K | $59K | -$136K | -$31K |
| Capital Expenditure | -$9.9K | -$1 | -$5.5K | -$1 | $0 | -$13K | $0 |
| **Free Cash Flow** | -$86K | -$109K | -$61K | -$71K | $59K | -$150K | -$31K |
| **Investing Cash Flow** | -$9.9K | -$5.3K | -$5.5K | $537 | -$16K | -$14K | -$2.8K |
| **Financing Cash Flow** | $1.10M | $106K | $118K | -$4.4K | -$4.3K | $228K | $65K |
| **Net Change in Cash** | $1.01M | -$8.6K | $57K | -$75K | $39K | $78K | $31K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Gross Margin** | 27.4% | 34.4% |
| **Operating Margin** | -52.3% | -2739.0% |
| **Net Profit Margin** | -56.5% | -2838.0% |
| Return on Equity (ROE) | -- | -709.0% |
| Return on Assets (ROA) | -66.5% | -27.2% |
| Current Ratio | 0.22x | 3.23x |
| Quick Ratio | 0.18x | 0.64x |
| Debt to Equity | -- | 10.22x |
| **Revenue Growth (YoY)** | +10879.7% | -- |
| Gross Profit Growth (YoY) | +8636.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 35.3% | 37.7% | 30.5% | 27.4% | -- | -- | -- |
| **Operating Margin** | -38.0% | -31.3% | -50.7% | -52.3% | -- | -- | -- |
| **Net Profit Margin** | -41.5% | -34.8% | -54.9% | -56.5% | -- | -- | -- |
| Return on Equity (ROE) | -51.3% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -20.3% | -50.3% | -56.9% | -66.5% | -- | -- | -- |
| Current Ratio | 1.09x | 0.32x | 0.32x | 0.22x | -- | -- | -- |
| Quick Ratio | 0.85x | 0.16x | 0.19x | 0.18x | -- | -- | -- |
| Debt to Equity | 0.14x | -- | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +36.8% | +228.9% | +145.6% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +8.6% | +616.7% | +380.9% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -149.4% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -175.3% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -228.0% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -244.9% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
